ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants
Public ClinicalTrials.gov record NCT02737501. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Multicenter Open-label Study of Brigatinib (AP26113) Versus Crizotinib in Patients With ALK-positive Advanced Lung Cancer
Study identification
- NCT ID
- NCT02737501
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Ariad Pharmaceuticals
- Industry
- Enrollment
- 275 participants
Conditions and interventions
Interventions
- Brigatinib Drug
- Crizotinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 25, 2016
- Primary completion
- Jul 27, 2020
- Completion
- Jan 28, 2021
- Last update posted
- Aug 19, 2021
2016 – 2021
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| USOR - Arizona Oncology Associates - Sedona | Sedona | Arizona | 86336 | — |
| Kaiser Permanente Bellflower Medical Offices | Bellflower | California | 90706 | — |
| University of Colorado Cancer Center | Aurora | Colorado | 80045 | — |
| Rocky Mountain Cancer Centers - Boulder | Boulder | Colorado | 80303-1385 | — |
| Sylvester Comprehensive Cancer Center | Deerfield Beach | Florida | 33442 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| West Michigan Cancer Center | Kalamazoo | Michigan | 49007 | — |
| Minnesota Oncology | Coon Rapids | Minnesota | 55433 | — |
| Montefiore Medical Center | The Bronx | New York | 10461 | — |
| Oncology Hematology Care - Blue Ash | Cincinnati | Ohio | 45242-5665 | — |
| Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | — |
| Virginia Cancer Specialists - Fairfax Office | Fairfax | Virginia | 22031 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02737501, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2021 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02737501 live on ClinicalTrials.gov.